“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
From February 26th-28th, IRBM’s Heidi Kingdon Jones and Dr. Raffaele Ingenito are in Tokyo attending Asia TIDES: Oligonucleotides and Peptide Therapeutics. On Wednesday, February 27th at 4pm, Dr. Ingenito will give a talk in the Peptide Track addressing the key issues in peptide drug development.
We look forward to discussing how the innovative drug discovery services of IRBM can accelerate the development of your biotherapeutics. Please get in touch with Heidi and Raffaele to arrange a meeting during the event!